Dicerna Pharmaceuticals Inc
DRNADelisted Dec 28, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001399529
Dicerna Pharmaceuticals Inc was delisted on Dec 28, 2021; its insiders filed their last Form 4 on Dec 29, 2021; 173 institutions reported holding it in 13F filings for Q3 2021, worth $1.28B in total; Maverick Capital was the only superinvestor holding it.
Superinvestors holding DRNA, Q3 2021
1 superinvestor reports holding Dicerna Pharmaceuticals Inc on Form 13F, worth $26.4M in total. Weight is Dicerna Pharmaceuticals Inc's share of each 13F portfolio; actions compare shares with Q2 2021.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Maverick CapitalLee Ainslie | 0.3% | 1,310,530 | $26.4M | Added+0.2% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of DRNA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2021
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+0.2%)
- Sold out
- ARK Invest
Q2 2021
2 superinvestors holding at quarter end
- New
- ARK Invest
- Reduced
- Maverick Capital (−3.3%)